Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Discovery of Propylene Glycol for its New Powerful Tissue-Regenerative-and-Tissue-Microbicidal Properties in Very Effectively Treating Common Topical Diseases by Scientist, Dr. Win L. Chiou


News provided by

Win L Chiou

Mar 24, 2023, 09:24 ET

Share this article

Share toX

Share this article

Share toX

BURR RIDGE, Ill., March 24, 2023 /PRNewswire/ -- There are numerous topical diseases occurring often in our lives. They include infections of skin, scalp, nails, ears, noses, oral gums and cavity, teeth and genitals. Infections may be caused by bacteria, fungi, viruses or a combination of any of them. Identification of infecting microorganisms, an expensive, time-consuming procedure, is often carried out for successful treatments. Injuries, insect bites and burns are also common; prevention of infection and quick healing of wounds without scarring are of major concern.

Continue Reading
Dr. Win L. Chiou
Dr. Win L. Chiou

Currently, there are hundreds or thousands of commercial products available for these uses with many requiring expensive prescriptions. It is ideal if we could find a safe inexpensive compound that is a powerful tissue microbicide and is also an effective tissue-regenerative (probably indicative of immune enhancement, anti-inflammation and anti-allergy) agent. Such a compound could then serve as a basis to prepare a "universal" (eyes excepted) household product to initially self-manage a very large number of topical disorders at home or during travel, thereby saving prolonged body suffering and potentially large medical costs. This should be highly valuable for both developed and under-developed countries.

The main purpose of this press release is to promote awareness of discovery by Dr. Chiou of such a miraculous compound, propylene glycol (PG), generally regarded as safe by the Food and Drug Administration. This release will also demystify common bad connotations of the PG.  

Dr. Chiou, near 85, is a renown retired professor from University of Illinois (1971-2005), has 200+ publications and 6 patents (1), is regarded as a top expert in pharmacokinetics (2), and was former FDA/pharma consultant. He issued two releases recently: "Conventional theories of photoaging and skin cancer challenged by scientist, Dr. Win L. Chiou" and "Possible dangers and SPF misconceptions of sunscreens for sunbathing investigated by scientist, Dr. Win L Chiou".

Chiou discovered that contrary to an early study, PG in aqueous solutions could quickly disappear into skin, nails, scalp and mucous membrane, indicative of good absorption (3,). In vitro studies (4) showed, for example, a 40% PG aqueous solution killed 50% of Herpes Simplex Virus 1 in one minute while an 80% PG solution killed 99.9% of viruses. For P. acnes, E. Coli, S. aureus, C. albians, A. niger, and others, 99.99% of them was killed in one minute. The above clearly indicates that PG can serve as an extremely powerful tissue microbicide, in sharp contrast to many antibiotics that are either weak in killing microorganisms or only inhibiting their growth. 

Although applications of tissue regeneration technology to medical uses have been extensively studied in recent decades, their uses in daily clinical practices seem rare or none. The expensive technology often requires isolation of stem cells and use of growth factors. Chiou may be the only one to date to report that a simple compound like PG can serve as a highly effective tissue-regenerative agent through its stem/progenitor cell rejuvenation (5). It could promote rapid wound healing after skin and gum infections, insect bites, bruises, and burns (4, 5; unpublished). In this regard, promotion of nail growth could be visible in days or weeks after twice daily applications of 50-80% PG solution to cubicles of seniors' toenails or injured toenails that were slow to grow (5).

Chiou said based on above exceedingly favorable pharmacokinetic (good absorption) and pharmacodynamic (microbicidal and regenerative properties) characteristics, one can theoretically predict with 100% confidence that properly formulated PG products can serve as effective household products to provide quick relief for topical disorders/discomforts. Such a prediction has been repeatedly confirmed by studies/observations to date. His prediction will be further reconfirmed by future clinical studies. His prediction in 1971 (6) on universal applications of solid dispersion/amorphous dispersion approach to enhance oral drug absorption has been confirmed and re-confirmed (2,671 citations per Google) even though only two human subjects (one being Chiou) were initially tested (6). Conceivably, PG may also have a role in skin cancer treatment and research.   

Aging reversal of Chiou's gum and tooth, probably first of its kind (5): About 6 years ago, he had serious gum recession, gingivitis, deep air pockets (up to 8 mm), and a loose tooth. After nightly PG applications around teeth and gum for 2 months, the loose tooth was firmed up and air pockets reduced. Recently his dentist told him that his gum looked like he was in his 20's and there were hardly any air pockets. His peritonitis and even root canal were rapidly managed by PG preparations.

PG exists naturally in our body as a metabolite of gut flora. It is commonly used as solvent in cosmetics and drugs, and as preservative in meat, cakes, and canned foods. In low quantities used even at high concentrations, PG should be considered as one of safest compounds available and the reported PG phobias may be largely misdirected. Interestingly, no irritant reactions were found in all 16 subjects tested with 50% PG (7) and pure PG produced virtually no (3) or only marginal (7) irritant properties.

PG's mild irritant/sensitivity reactions in patch tests were obtained only after 4 days of   unrealistic skin occlusion; even distilled water (7) tested positive, at a rate of 3%. Probably millions of unscented 50% PG deodorant sticks used are known not to have significant adverse effects.

Unsurprisingly, a moisturizer containing 25% PG was recently found to have a Sun Protection Factor of 2.8 (N = 5) supporting anti-inflammatory property of PG. A gel containing 80% PG could shrink and peel several large, dark eczematous lesions of Chiou in about one month without scarring and irritation. Also, reddish skin burn (3x6 cm) with some bleeding was successfully healed with only two applications covered with gauzes.

Win Chiou, President of Chiou Consulting Inc, can be reached at 630-789-9081 or at [email protected].

SOURCE Win L Chiou

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.